Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

D

devadmin

@devadmin
administrators

Forum Update: Supporting Community-Led Discussion

The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.

Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:

  • Correct any misunderstandings
  • Provide guidance when questions remain unanswered after a few days
  • Support discussions where official clarification is needed

Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.

Thank you for being part of the conversation.

About
Posts
109
Topics
109
Shares
0
Groups
8
Followers
0
Following
0

Posts

Recent Best Controversial

  • Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising
    D devadmin

    @Agency and @Manufacturer

    The PAAB has posted a new guidance on study durations as a results of our global benchmarking initiative and based on industry consultation. Please see the Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising and post any questions you have regarding this document, below.

    Please note that this guidance will go into effect April 18th. PAAB will not be accepting submissions with updated data prior to this date to ensure all companies have sufficient time to assess the changes.

    Guidance on Code Application

  • Registration Tutorial
    D devadmin

    Lets start with a quick registration video.

    PAAB Forum Tutorials

  • Digital Conference Myths
    D devadmin

    Check out some of the top Digital Conference Myths we've seen to date.

    Digital Conferences

  • Guidance on the eFiles Platform Ticketing and Tagging Functionality
    D devadmin

    Enter your comments here.

    Guidance on Submission Procedures

  • Advisory on Exclusivity Claims for Indications
    D devadmin

    Expanding the approach to exclusivity claims

    @Agency and @Manufacturer A new advisory has been posted on Exclusivity Claims for Indications. If you have any questions, please post below:

    Guidance on Code Application extneral advisory indication

  • Guidance on Submission Process and Format Requirements
    D devadmin

    Please leave questions on this guidance below:

    Guidance on Submission Procedures submission process guidance

  • Guidance on the Presentation of Burdens of Disease in Advertising
    D devadmin

    Please share your comments and questions below. The full article can be found here

    As well as some Examples

    Guidance on Code Application external guidance document disease info disease consequences disease burden
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups